Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Resectable Melanoma”

30 trials

Showing 20 of 30 results

Testing effectiveness (Phase 2)Study completedNCT00525031
What this trial is testing

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 55
Testing effectiveness (Phase 2)WithdrawnNCT04007588
What this trial is testing

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Dana-Farber Cancer Institute
Not applicableEnded earlyNCT02716077
What this trial is testing

Early FDG PET in Melanoma

Who this might be right for
Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma
Abramson Cancer Center at Penn Medicine 6
Large-scale testing (Phase 3)WithdrawnNCT01861938
What this trial is testing

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Who this might be right for
High Risk HLA-A2+ MelanomaMetastatic Disease
Hadassah Medical Organization
Not applicableUnknownNCT05171374
What this trial is testing

PRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVMelanoma
MelanomaPRO, Russia 500
Testing effectiveness (Phase 2)Study completedNCT00590824
What this trial is testing

Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
University of Wisconsin, Madison 23
Testing effectiveness (Phase 2)Study completedNCT02872259
What this trial is testing

BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma

Who this might be right for
Melanoma
Haukeland University Hospital 74
Very early researchStudy completedNCT00962845
What this trial is testing

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Rutgers, The State University of New Jersey 20
Early research (Phase 1)UnknownNCT04197882
What this trial is testing

Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 33
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT02410863
What this trial is testing

Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 10
Large-scale testing (Phase 3)Ended earlyNCT01280565
What this trial is testing

Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit

Who this might be right for
Metastatic Melanoma
AB Science 134
Testing effectiveness (Phase 2)UnknownNCT04248387
What this trial is testing

Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma

Who this might be right for
Melanoma Stage IIIB-IV
Fudan University 100
Large-scale testing (Phase 3)Ended earlyNCT01013623
What this trial is testing

Stage IV Surgery Versus Best Medical Therapy

Who this might be right for
Stage IV Resectable Melanoma
Saint John's Cancer Institute 12
Testing effectiveness (Phase 2)Looking for participantsNCT04331093
What this trial is testing

Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

Who this might be right for
Acral Melanoma
Di Wu 40
Very early researchNot Yet RecruitingNCT06212388
What this trial is testing

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Who this might be right for
Melanoma
Xijing Hospital 10
Testing effectiveness (Phase 2)UnknownNCT05907512
What this trial is testing

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8
Fudan University 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04139902
What this trial is testing

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Diwakar Davar 48
Testing effectiveness (Phase 2)Study completedNCT00715793
What this trial is testing

Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hussein Tawbi 39
Early research (Phase 1)Study completedNCT02434354
What this trial is testing

A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma

Who this might be right for
Malignant Melanoma
Abramson Cancer Center at Penn Medicine 33
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation